Market revenue in 2023 | USD 725.3 million |
Market revenue in 2030 | USD 2,058.2 million |
Growth rate | 16.1% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.59% in 2024. Horizon Databook has segmented the UK biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of sophisticated healthcare infrastructure, collaborations between key market players, and the launch of novel products are anticipated to contribute to market growth in the UK. Government support & initiatives are expected to further propel the country’s biochip market in the coming years.
Commercial partnerships between the government and key players and increasing companies academia collaborations are further supporting the country’s market. For instance, in September 2022, the National Human Genome Research Institute (NHGRI) awarded around USD 3.35 million over 5 years to introduce the Genome Research Experiences.
The initiative will develop partnerships between universities and allow undergraduate students to conduct genomic research. Moreover, rising research efforts to leverage biochip applications in drug discovery and diagnostics, coupled with various strategic initiatives undertaken by market participants are projected to drive the UK biochip market.
Horizon Databook provides a detailed overview of country-level data and insights on the UK biochip market, including forecasts for subscribers. This country databook contains high-level insights into UK biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account